Yes, folic acid supplementation is required while on TREXJECT (subcutaneous methotrexate)
Folic acid supplementation is strongly recommended for all patients receiving TREXJECT to reduce gastrointestinal, hepatic, and other adverse effects without compromising efficacy. 1, 2
Dosing Recommendations
The standard approach is:
- At least 5 mg of folic acid per week 2
- Typically given daily except on the day(s) methotrexate is administered to avoid potentially reducing efficacy 1
- Doses can range from 1 mg daily to 5 mg weekly depending on the protocol
Evidence for Benefit
Folic acid supplementation provides clear protective effects:
- 26% reduction in gastrointestinal side effects (nausea, vomiting, abdominal pain) 3
- 77% reduction in abnormal liver enzyme elevations 1
- 61% reduction in treatment discontinuation for any reason 3
- Trend toward reduced stomatitis/mouth sores (though not statistically significant) 3
The evidence shows no significant reduction in methotrexate efficacy when folic acid is supplemented, making this a high benefit-to-risk intervention 3, 4, 5.
Practical Implementation
Start folic acid at the same time you initiate TREXJECT - do not wait for side effects to develop 6. This empirical approach is:
- Cost-effective
- Associated with high benefit-to-risk ratio
- Prevents rather than treats toxicity
Folic Acid vs. Folinic Acid
Use folic acid rather than folinic acid for routine supplementation 1:
- Equally effective at preventing side effects
- Significantly less expensive
- Easier to manage
- No difference in efficacy outcomes
Folinic acid is reserved for rescue therapy in high-dose methotrexate toxicity scenarios, not for routine low-dose weekly therapy like TREXJECT.
Common Pitfalls to Avoid
⚠️ Do not skip folic acid supplementation - approximately 15-20% of patients still do not receive it despite strong guideline recommendations 7
⚠️ Do not give folic acid on the same day as methotrexate - this timing separation is recommended to theoretically preserve methotrexate efficacy, though evidence for this is based on expert consensus 1
⚠️ Do not use excessive doses - while large doses (>7 mg weekly) may further reduce side effects, they could potentially reduce methotrexate efficacy 1
Supporting Rationale
Low folate status at baseline is an independent risk factor for subsequent methotrexate toxicity 6. Since methotrexate works as an antifolate agent, supplementation logically addresses the mechanism of many side effects while the drug's anti-inflammatory effects in rheumatic diseases appear to work through different pathways that are not antagonized by folate replacement 1.